Correlation Between Lipocine and GOLDMAN

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Lipocine and GOLDMAN at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Lipocine and GOLDMAN into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Lipocine and GOLDMAN SACHS GROUP, you can compare the effects of market volatilities on Lipocine and GOLDMAN and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Lipocine with a short position of GOLDMAN. Check out your portfolio center. Please also check ongoing floating volatility patterns of Lipocine and GOLDMAN.

Diversification Opportunities for Lipocine and GOLDMAN

0.62
  Correlation Coefficient

Poor diversification

The 3 months correlation between Lipocine and GOLDMAN is 0.62. Overlapping area represents the amount of risk that can be diversified away by holding Lipocine and GOLDMAN SACHS GROUP in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on GOLDMAN SACHS GROUP and Lipocine is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Lipocine are associated (or correlated) with GOLDMAN. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of GOLDMAN SACHS GROUP has no effect on the direction of Lipocine i.e., Lipocine and GOLDMAN go up and down completely randomly.

Pair Corralation between Lipocine and GOLDMAN

Given the investment horizon of 90 days Lipocine is expected to under-perform the GOLDMAN. In addition to that, Lipocine is 3.16 times more volatile than GOLDMAN SACHS GROUP. It trades about -0.21 of its total potential returns per unit of risk. GOLDMAN SACHS GROUP is currently generating about -0.34 per unit of volatility. If you would invest  9,893  in GOLDMAN SACHS GROUP on September 3, 2024 and sell it today you would lose (323.00) from holding GOLDMAN SACHS GROUP or give up 3.26% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy25.0%
ValuesDaily Returns

Lipocine  vs.  GOLDMAN SACHS GROUP

 Performance 
       Timeline  
Lipocine 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Lipocine are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of very unsteady fundamental indicators, Lipocine displayed solid returns over the last few months and may actually be approaching a breakup point.
GOLDMAN SACHS GROUP 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days GOLDMAN SACHS GROUP has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest unfluctuating performance, the Bond's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for GOLDMAN SACHS GROUP investors.

Lipocine and GOLDMAN Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Lipocine and GOLDMAN

The main advantage of trading using opposite Lipocine and GOLDMAN positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Lipocine position performs unexpectedly, GOLDMAN can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in GOLDMAN will offset losses from the drop in GOLDMAN's long position.
The idea behind Lipocine and GOLDMAN SACHS GROUP pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.

Other Complementary Tools

Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Commodity Directory
Find actively traded commodities issued by global exchanges
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges